Volume IV, Issue 11

March 13, 2017
Trump Nominates Scott Gottlieb, MD, to Head FDA
Toni Clarke reporting for Reuters on 3.10.17:

U.S. President Donald Trump has chosen Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the U.S. Food and Drug Administration, the White House said on Friday.

According to the article:

If confirmed by the Senate, Gottlieb would be in charge of implementing Trump's plan to dramatically cut regulations governing food, drugs, cosmetics, dietary supplements and tobacco.

Gottlieb is well known on Capitol Hill, where he has testified multiple times on hot-button health issues, including complex drug pricing matters, and is viewed favorably by drug companies and pharmaceutical investors. He sits on the boards of several small drug and biotech companies and is an adviser to GlaxoSmithKline Plc.
CMS pick Seema Verma gets one step closer to confirmation
Ilene MacDonald, reporting for Fierce Healthcare on March 9, 2017:

The Senate agreed on Thursday to end the debate over the nomination of Seema Verma as the head of the Centers for Medicare & Medicaid Services and set up a final confirmation vote that will likely take place early next week.
According to Ms. MacDonald:

The 54-44 vote once again fell mostly across party lines, with 43 Democrats voting against ending the discussion. Bernie Sanders, I-Vt., also voted nay. Two Senators, Johnny Isakson, R-Ga., and Marco Rubio, R-Fla., did not vote.

Despite opposition from Democrats, it is likely she will be confirmed next week.

Verma is the president, CEO and founder of SVC Inc., a national health policy consulting company. She has close ties to Vice President Mike Pence, with whom she worked on Indiana's Medicaid expansion plan when he was governor.
Med Mal Rates Going Up
In the March edition of SFHN, Vanessa Orr interviews Matt Gracey, CEO of Danna-Gracey headquartered in Delray Beach.

"We are expecting the market to become more difficult for doctors as we transition from the soft market conditions that we have now to a harder market as a result of the increase in frequency of claims against Florida doctors, and the severity of judgments against doctors in Florida - both are increasing," according to Mr. Gracey.

"We're warning doctors to place their malpractice insurance with a well-valued, financially secure company because small and unnoted insurers will have even more trouble because they are only able to compete on pricing," said Gracey. "Their claims handling is also not as good as that of rated carriers - they are forced to settle claims that a bigger company would be defending."
Healthcare CEOs concerned about cyber threats but few are taking action
In March 6, 2017 press release, PwC reveals their latest survey results:

PwC's 20th Annual Global CEO Survey looked at the perspectives of 1,379 CEOs, which included responses from 56 healthcare leaders in 27 countries. The sector summary, 'A new treatment?: Healthcare findings from the 20th Annual Global CEO Survey' canvassed views from industry respondents about where we are now, what the future may hold and what business can do to make a positive difference.

The survey found that Most healthcare CEOs believe it's harder for businesses to gain and keep trust in the digital world, citing cyber threats as a growing concern and breaches in data security and ethics as the number one risk to stakeholders' trust. While most healthcare CEOs are taking action now on data security and ethics, few are taking action on cyber security activity.



Join Us    

About Us
Florida Health Industry Week in Review is published every Monday by

Each Monday morning we share the top healthcare headlines of the previous week and summarize
What Happened (WH) and
Why It Matters (WIM).

To learn how you can join our team of editorial contributors, contact Jeffrey Herschler .
Publisher of...

Week in Review,
Specialty Focus,
Updates in Pediatrics, FHIweekly &
Game Changers

Inside FloridaHealthIndustry.com

FHI logo cropped small version